Home / Products / Bromodomain Inhibitors Products

Bromodomain Inhibitors: Products

"Bromodomain Inhibitors" has 50 results in Products.
Sort by:
Results Per Page:

MZ 1 

(+)-JQ1 based Degrader (PROTAC®) that selectively degrades BRD4
6154
5 Citations

AT 1 

(+)-JQ1 based PROTAC® with selectivity for BRD4
6356
1 Review

(+)-JQ1 

Potent and selective BET bromodomain inhibitor; cell permeable
4499
12 Citations
2 Reviews

cis MZ 1 

Negative Control for MZ 1 (Cat. No. 6154)
6155
1 Citation

dBRD9 

Potent and selective BRD9 Degrader (PROTAC®)
6606
1 Citation

I-BET 151 dihydrochloride 

BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes
4650
4 Citations
2 Reviews

MS 436 

Potent and selective BRD4(1) inhibitor
5173

I-BRD9 

Potent and selective BRD9 inhibitor
5591
2 Citations

Lin28 1632 

RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor
6068

dBET1 

(+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo
6327

ZXH 3-26 

Potent and selective BRD4 Degrader (PROTAC®)
6713

LY 303511 

Negative control of LY 294002 (Cat. No. 1130)
2418

XMD 8-92 

ERK5/BMK1 inhibitor; also BRD4 inhibitor
4132
4 Citations

PFI 1 

BET bromodomain inhibitor
4445
2 Citations

Ischemin sodium salt 

CBP inhibitor; cell permeable
4695

Bromosporine 

Broad spectrum bromodomain inhibitor
4758

SGC-CBP30 

Potent CBP/p300 BRD inhibitor
4889
1 Citation

I-CBP 112 

Selective CBP/p300 BRD inhibitor
4891

OXF BD 02 

Selective BRD4(1) inhibitor
4928

PFI 3 

Potent and selective SMARCA2/4 and polybromo 1 inhibitor
5072

BAZ2-ICR 

Selective BAZ2 inhibitor
5266

OF 1 

Selective BRPF1B and BRPF2 inhibitor
5289

CPI 203 

BET bromodomain inhibitor; arrests cell cycle at G1 phase
5331
1 Citation
1 Review

GSK 5959 

Potent and selective BRPF1 inhibitor
5385

NI 57 

Potent and selective BRPF bromodomain inhibitor
5546

PFI 4 

Potent and selective BRPF1B bromodomain inhibitor
5576

BI 9564 

Potent and selective BRD9 and BRD7 inhibitor; orally active
5590

(-)-JQ1 

Negative control for (+)-JQ1
5603
2 Citations

GSK 2801 

Selective BAZ2A and BAZ2B inhibitor
5635

ISOX DUAL 

Dual BRD4 and CBP/p300 bromodomain inhibitor
5806

ISOX INACT 

Negative control for PF-CBP1
5808

LP 99 

Selective BRD7 and BRD9 inhibitor
5496

ent-LP 99 

Negative Control for LP 99
5497

NVS-CECR2-1 

Potent and selective CECR2 inhibitor
5744

NI 42 

High affinity BRPF inhibitor
5786

BAY 299 

Potent and selective BRD1 and TAF1 inhibitor
5970

TP 472N 

Negative control for TP 472
5999

TP 472 

Potent BRD9/7 inhibitor
6000
1 Citation

TC AC 28 

High affinity BET bromodomain ligand
6105

OTX 015 

BET bromodomain inhibitor; orally bioavailable
6181

GSK 6853 

Potent and selective BRPF1 inhibitor
6198

GSK 9311 hydrochloride 

Negative control for GSK 6853
6203

L Moses dihydrochloride 

High affinity and selective PCAF bromodomain inhibitor
6251

I-BET 762 

Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.
6521

TP 238 

CECR2 and BPTF/FALZ inhibitor
6670

VZ 185 

Potent and selective BRD7/9 Degrader (PROTAC®)
6936

cis-VZ 185 

Negative control for VZ 185 (Cat. No. 6936)
6939

dBRD9-A 

Potent BRD9 Degrader (PROTAC®)
6943

dBET6 

Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo
6945

ARV 771 

Potent BET bromodomain PROTAC®; also degrades BRD-tagged chimeric antigen receptors (CAR) in T cells
7256
page of 1
Back to Search Results
Apply
FiltersClear All
Category Clear
Small Molecules (50)
Citation Clear
1 or more (12)
10 or more (1)
Brand Clear
Tocris (50)